NCT05678361 (SLEPT) is a NA clinical trial of Sleep/Nap in Intrusive Memories, sponsored by University of Zurich.

Who is sponsoring NCT05678361?

NCT05678361 is sponsored by University of Zurich.

What drugs are being tested in NCT05678361?

Interventions in NCT05678361: Sleep/Nap.

What condition does NCT05678361 study?

NCT05678361 studies Intrusive Memories, PTSD.

Is NCT05678361 still recruiting?

NCT05678361 is currently completed. Last updated 10 January 2023.

Last reviewed 2023-01-10 · How we verify

NCT05678361: SLEPT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sleep's Influence on the Treatment of Intrusive Emotional

Completed NA Last updated 10 January 2023

What this trial tests

NA trial testing Sleep/Nap in Intrusive Memories in 42 participants. Completed in 1 December 2022.

Timeline

1 August 2018

Primary endpoint
1 December 2022

1 December 2022

Quick facts

Lead sponsor	University of Zurich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	42
Start date	1 August 2018
Primary completion	1 December 2022
Estimated completion	1 December 2022
Sites	1 location across Switzerland

Drugs / interventions tested

Sleep/Nap

Conditions studied

Intrusive Memories — all drugs for Intrusive Memories →
PTSD — all drugs for PTSD →

Sponsor

University of Zurich

Who can join

Adults 18 to 65, any sex, with Intrusive Memories or PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Intrusive memories represent a debilitating core feature of PTSD, one of the most prevalent psychiatric disorders following trauma. Exposure therapy is amongst the most successful treatments of PTSD that is recommended by most of the current national and international guidelines. The current study aims to test whether sleep as adjunct to written exposure sessions, a type of exposure- based treatment for PTSD, may boost the effectiveness of the therapy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intrusive Memories

Currently open trials in the same condition.

NCT07419594 — Estradiol and Intrusive Memories · NA · recruiting
NCT04871269 — The Effect of Dronabinol on the Acquisition and Consolidation of Trauma-Associated Memories · NA · active not recruiting

Other University of Zurich trials

Trials by the same sponsor.

NCT07485699 — Soy Processing and Food Allergy · NA · not yet recruiting
NCT07516912 — Evaluation of Free STI Testing Pilot Projects in Lucerne and Zurich, Switzerland · not yet recruiting
NCT07473115 — Individualized Analgesia in the Intensive Care Unit With a New Pain Assessment Bundle and Protocolized Analgesia Adjustm · not yet recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT06481982 — Value of Advanced MRI Techniques in the Assessment of Endometriosis · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05678361 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Zurich
Last refreshed: 10 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05678361.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing